The EORTC Quality of Life Group (QLG) aims to better understand the effects of cancer and its treatments on health-related quality of life (HRQoL) for patients across diverse populations and cultures.
Members of the group develop and refine questionnaires for use in oncology clinical trials and other well-designed research studies as well as for clinical practice. They also collaborate with other EORTC disease-oriented groups to implement quality of life measurement in clinical trials.